Development of a GAL4-VP16/UAS trans-activation system for tissue specific expression in Medicago truncatula

PLoS One. 2017 Nov 29;12(11):e0188923. doi: 10.1371/journal.pone.0188923. eCollection 2017.

Abstract

Promoters with tissue-specific activity are very useful to address cell-autonomous and non cell autonomous functions of candidate genes. Although this strategy is widely used in Arabidopsis thaliana, its use to study tissue-specific regulation of root symbiotic interactions in legumes has only started recently. Moreover, using tissue specific promoter activity to drive a GAL4-VP16 chimeric transcription factor that can bind short upstream activation sequences (UAS) is an efficient way to target and enhance the expression of any gene of interest. Here, we developed a collection of promoters with different root cell layers specific activities in Medicago truncatula and tested their abilities to drive the expression of a chimeric GAL4-VP16 transcription factor in a trans-activation UAS: β-Glucuronidase (GUS) reporter gene system. By developing a binary vector devoted to modular Golden Gate cloning together with a collection of adapted tissue specific promoters and coding sequences we could test the activity of four of these promoters in trans-activation GAL4/UAS systems and compare them to "classical" promoter GUS fusions. Roots showing high levels of tissue specific expression of the GUS activity could be obtained with this trans-activation system. We therefore provide the legume community with new tools for efficient modular Golden Gate cloning, tissue specific expression and a trans-activation system. This study provides the ground work for future development of stable transgenic lines in Medicago truncatula.

MeSH terms

  • Cloning, Molecular
  • Genes, Plant
  • Medicago truncatula / genetics*
  • Promoter Regions, Genetic
  • Trans-Activators / genetics*
  • Transcriptional Activation*

Substances

  • Gal-VP16
  • Trans-Activators

Grants and funding

This work was supported by the "Laboratoire d'Excellence (LABEX)" TULIP (ANR-10-LABX-41). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.